Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuvshinoff, B. W.
Right arrow Articles by Coit, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuvshinoff, B. W.
Right arrow Articles by Coit, D. G.

Annals of Surgical Oncology, Vol 4, Issue 3 252-258, Copyright © 1997 by Society of Surgical Oncology

ARTICLES

Computed tomography in evaluation of patients with stage III melanoma

B. W. Kuvshinoff, C. Kurtz and D. G. Coit
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

BACKGROUND: Metastatic disease is detected infrequently by computed tomography (CT) in early stage melanoma. The diagnostic yield of routine CT for stage III melanoma is less established, despite extensive use in clinical practice. METHODS: Charts from 347 asymptomatic patients with stage III melanoma were reviewed. Findings suggestive of metastatic melanoma identified by head or body CT, chest radiography, bone scan, or liver function studies were confirmed histologically or by progression of disease. RESULTS: Individual CT scans identified 33/788 (4.2%) instances of metastatic melanoma, with 66/788 (8.4%) false positive studies. No metastases were identified among 104 head CT scans. Chest CT had the highest yield in patients with cervical adenopathy (7/35, 20%), and the lowest yield with groin adenopathy (1/50, 2%). Pelvic CT diagnosed metastases in 7/94 (7.4%) patients with groin adenopathy, but no patients with palpable axillary (n = 76) or cervical (n = 21) nodes. Metastatic melanoma was diagnosed in 11/136 (8.1%) patients having complete body CT imaging (chest, abdomen, and pelvis), including six patients (4.4%) identified by CT alone. CONCLUSIONS: Routine CT in patients with clinical stage III melanoma infrequently identifies metastatic disease. Head CT in the asymptomatic patient, chest CT in patients with groin adenopathy, and pelvic CT in the presence of axillary or cervical adenopathy are not indicated. Selective use of chest CT in patients with cervical adenopathy or pelvic CT in the presence of groin disease may be useful.


This article has been cited by other articles:


Home page
 Ann. Surg. Oncol.Home page
J. S. Gold, D. P. Jaques, K. J. Busam, M. S. Brady, and D. G. Coit
Yield and Predictors of Radiologic Studies for Identifying Distant Metastases in Melanoma Patients with a Positive Sentinel Lymph Node Biopsy
Ann. Surg. Oncol., July 1, 2007; 14(7): 2133 - 2140.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
T. Z. Belhocine, A. M. Scott, E. Even-Sapir, J.-L. Urbain, and R. Essner
Role of Nuclear Medicine in the Management of Cutaneous Malignant Melanoma
J. Nucl. Med., June 1, 2006; 47(6): 957 - 967.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
L. J. A. Strobbe, A. Jonk, A. A. M. Hart, J. L. Peterse, T. Wobbes, O. E. Nieweg, and B. B. R. Kroon
The Value of Cloquet's Node in Predicting Melanoma Nodal Metastases in the Pelvic Lymph Node Basin
Ann. Surg. Oncol., April 1, 2001; 8(3): 209 - 214.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. D. Wagner, D. Schauwecker, D. Davidson, J. J. Coleman III, S. Saxman, G. Hutchins, C. Love, and J. T. Hayes
Prospective Study of Fluorodeoxyglucose–Positron Emission Tomography Imaging of Lymph Node Basins in Melanoma Patients Undergoing Sentinel Node Biopsy
J. Clin. Oncol., May 1, 1999; 17(5): 1508 - 1508.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the Society of Surgical Oncology.